DOI:
10.1055/s-00000054
Pharmacopsychiatry
LinksClose Window
References
Bugarski-Kirola D, Blaettler T, Arango C. et al.
Bitopertin in negative symptoms of schizophrenia – results from the Phase III FlashLyte and DayLyte studies.
Biol Psychiatry 2017;
82: 8-16
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.